col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

154 Results       Page 1

American Society for Biochemistry and Molecular Biology: Journal of Biological Chemistry
  original article Date Title Authors   All Authors
1 [GO] 2024―May―13 Kinetic comparison of all eleven viral polyprotein cleavage site processing events by SARS-CoV-2 Main Protease using a linked protein FRET platform Calem Kenward, Marija Vuckovic, Mark Paetzel, Natalie C.J. Strynadka
2 [GO] 2024―May―07 Phosphorylation in the Ser/Arg-Rich Region of the Nucleocapsid of SARS-CoV-2 Regulates Phase Separation by Inhibiting Self-Association of a Distant Helix Hannah Stuwe, Patrick N. Reardon, Zhen Yu, Sahana Shah, Kaitlyn Hughes, Elisar J. Barbar
3 [GO] 2024―Mar―25 Abstract 1134 Exploring the Relation Between COVID-19 Clinical Presentations and Biomarker Alterations: Insights from a Comprehensive Study at the Huehuetenango Regional Hospital, Guatemala Magali Coyoy-Say
4 [GO] 2024―Mar―25 Abstract 2335 Ruining title: Impact of COVID-19 on Antimicrobial Resistance Reporting in New York State: did it contribute to the emergence of novel resistance patterns? Mahmoud Aly
5 [GO] 2024―Mar―25 Abstract 1070 A Tale of Two RNAs: How Nonstructural Protein 1 of SARS Coronavirus Selectively Suppresses Host mRNA Translation Anita Nag, Laurie Melton, Mario Romero, Ethan Lewis
6 [GO] 2024―Mar―25 Abstract 1574 Structural insights into the dynamics of bat coronavirus spike glycoprotein Toheeb Balogun, Cory Acreman, Fiona Kearns, Alexandra Tse, Emily Miller, Kartik Chandran, et al. (+2)
7 [GO] 2024―Mar―25 Abstract 1179 Impact of SARS-COV NSP1 on RNA Transcription and Metabolism Mario Romero, Anita Nag
8 [GO] 2024―Mar―25 Abstract 2061 The mechanistic basis for immune evasion by Orf9b of SARS-CoV-2 Noah Sherer, Abhishek Bastiray, Xiao-Ru Chen, Iktae Kim, Tatyana Igumenova, Jae-Hyun Cho
9 [GO] 2024―Mar―25 Abstract 1316 Identifying the Oligomerization State of the Transmembrane Domain of the ORF7b Accessory Protein Found in SARS-CoV-2 & Exploring Potential Means of Reducing Viral Pathogenicity Nathan Cabrera, Timothy Reichart
10 [GO] 2024―Mar―25 Abstract 1458 Biochemical and structural characterization of second-generation inhibitors targeting the SARS-CoV-2 3CL protease Michael Muczynski, Joseph Engel, Franck Amblard, Dharmeshkumar Patel, Raymond Schinazi, Ladislau Kovari
11 [GO] 2024―Mar―25 Abstract 2140 Advancing Cell-Penetrating Peptides (CPPs) in Drug Delivery: Synthesis and Characterization of Novel CPP SARS-CoV-2 Fluorophore Conjugates Lillie Geiersbach, Shailesh Ambre
12 [GO] 2024―Mar―25 Abstract 1217 SARS-CoV-2 Main Protease Inhibitor High-Throughput Screen Renee Delgado, Jyoti Vishwakarma, Seyed Moghadasi, Yuka Otsuka, Louis Scampavia, Justin Shumate, et al. (+2)
13 [GO] 2024―Mar―25 Abstract 1553 Identification of a SARS-CoV-2 Mpro inhibitor from large chemical libraries using a consensus pharmacophore Marco Velasco-Velazquez, Angel Ruiz-Moreno, Raziel Cedillo-González, Luis Cordova-Bahena, José Medina-Franco
14 [GO] 2024―Mar―25 Abstract 1091 The biochemical mechanism of SARS-CoV-2 nucleocapsid protein hyperphosphorylation Ya Ha, Song Chen, Zunyu He, Jean Kanyo, Tukiet Lam, Grace Ha, Brett Lindenbach
15 [GO] 2024―Mar―25 Abstract 1713 Shaping antiviral strategies with potent and selective non-covalent SARS-CoV-2 papain-like protease inhibitors Abdullah Al-Homoudi, Hariprased Aruri, Dineshsinha Chauhan, Olivia Haskin, Jacob Tartamella, Joseph Engel, et al. (+2)
16 [GO] 2024―Mar―25 Abstract 2115 SARS-CoV-2 polyprotein substrate regulates the stepwise Mpro cleavage reaction MANJU NARWAL, Jean-Paul Armache, Thomas Edwards, Katsuhiko Murakami
17 [GO] 2024―Mar―25 Abstract 2343 RNA phage Qβ display system for mapping SARS-CoV-2 spike protein functional domain and monitoring anti-S antibodies. Alain Bopda Waffo, Nadia Alatoom
18 [GO] 2024―Mar―25 Abstract 1062 An insight into the molecular interaction of SARS-CoV-2 variants of concern with human ACE2 protein Nabanita Mandal, Soumya Rath
19 [GO] 2024―Mar―25 Abstract 2062 Biophysical basis of interaction of ORF9b of SARS-CoV-2 with human Tom70 Abhishek Bastiray, Noah Sherer, Iktae Kim, Jae-Hyun Cho
20 [GO] 2023―Dec―17 A short sequence in the tail of SARS-CoV-2 envelope protein controls accessibility of its PDZ Binding Motif to the cytoplasm. Benoit Neitthoffer, Flavio Alvarez, Florence Larrous, Célia Caillet Saguy, Sandrine Etienne Manneville, Batiste Boëda
21 [GO] 2023―Nov―15 Mapping immunological and host receptor binding determinants of SARS-CoV spike protein utilizing the Qubevirus platform Carrie Sanders, Aristide Dzelamonyuy, Augustin Ntemafack, Nadia Alatoom, Godwin Nchinda, Millie M. Georgiadis, Alain Bopda Waffo
22 [GO] 2023―Oct―27 E3 ubiquitin ligase ZBTB25 suppresses beta coronavirus infection through ubiquitination of the main viral protease MPro Travis B. Lear, Áine N. Boudreau, Karina C. Lockwood, Elise Chu, Daniel P. Camarco, Qing Cao, et al. (+5)
23 [GO] 2023―Oct―19 Assembly of SARS-CoV-2 ribonucleosomes by truncated N* variant of the nucleocapsid protein Armin N. Adly, Maxine Bi, Christopher R. Carlson, Abdullah M. Syed, Alison Ciling, Jennifer A. Doudna, et al. (+2)
24 [GO] 2023―Oct―12 Reversible and irreversible inhibitors of coronavirus Nsp15 endoribonuclease Jerry Chen, Rabih Abou Farraj, Daniel Limonta Velazquez, Seyed Amir Tabatabaei Dakhili, Evan M. Kerek, Ashim Bhattacharya, et al. (+9)
25 [GO] 2023―Oct―12 The solution structure of the heavy chain-only C5-Fc nanobody reveals exposed variable regions that are optimal for COVID-19 antigen interactions Xin Gao, Joseph W. Thrush, Jayesh Gor, James H. Naismith, Raymond J. Owens, Stephen J. Perkins
26 [GO] 2023―Oct―12 SARS-CoV-2 papain-like protease (PLpro) plays multiple roles in regulating cellular proteins in the endoplasmic reticulum Mei Yang, Jennifer Mariano, Rebecca Su, Christopher E. Smith, Sudipto Das, Catherine Gill, et al. (+4)
27 [GO] 2023―Jul―05 Heme binding to the SARS-CoV-2 spike glycoprotein Samuel L. Freeman, A. Sofia F. Oliveira, Andrea E. Gallio, Annachiara Rosa, Maria K. Simitakou, Christopher J. Arthur, et al. (+3)
28 [GO] 2023―Jun―24 Interferon at the crossroads of SARS-CoV-2 infection and COVID-19 disease Charles E. Samuel
29 [GO] 2023―Jun―24 SARS-CoV-2 protein ORF8 limits expression levels of Spike antigen and facilitates immune evasion of infected host cells Ik-Jung Kim, Yong-ho Lee, Mir M. Khalid, Irene P. Chen, Yini Zhang, Melanie Ott, Eric Verdin
30 [GO] 2023―Jun―03 Contribution of the catalytic dyad of SARS-CoV-2 main protease to binding covalent and noncovalent inhibitors Andrey Kovalevsky, Annie Aniana, Leighton Coates, Peter V. Bonnesen, Nashaat T. Nashed, John M. Louis
31 [GO] 2023―May―16 Identification of SARS-CoV-2 PLpro and 3CLpro human proteome substrates using substrate phage display coupled with protein network analysis Yini Li, Mengzhun Guo, Lijia Ma, Bobo Dang
32 [GO] 2023―May―13 Neutrophil Elastase decreases SARS-CoV-2 Spike protein binding to human bronchial epithelia by clipping ACE-2 ectodomian from the epithelial surface Apparao B. Kummarapurugu, Adam M. Hawkridge, Jonathan Ma, Stephanie Osei, Rebecca K. Martin, Shuo Zheng, Judith A. Voynow
33 [GO] 2023―May―04 Kinetic analysis of RNA cleavage by coronavirus Nsp15 endonuclease: Evidence for acid base catalysis and substrate dependent metal ion activation Tong Huang, Kimberly C. Snell, Nidhi Kalia, Shahbaz Gardezi, Lily Guo, Michael E. Harris
34 [GO] 2023―Apr―28 The role of high cholesterol in SARS-CoV-2 infectivity. Hao Wang, Zixuan Yuan, Mahmud Arif Pavel, Sonia Mediouni Jablonski, Joseph Jablonski, Robert Hobson, et al. (+3)
35 [GO] 2023―Apr―13 Abstract 2150: Developing a COVID-19 Yeast Oral Vaccine for Low Income Countries Christopher Bresnahan, Nicanor Austriaco, Taylor Brysgel, Noah Kozub
36 [GO] 2023―Apr―13 Abstract 2663: Rising level of pulmonary dioxin might trigger CMV and HSV-1 reactivation via bHLH/PAS/AhR:ARNT transcription pathway in lungs of immunocompetent COVID-19 patients with ARDS Ilya Tsyrlov, Irina Shur
37 [GO] 2023―Apr―13 Abstract 1237: Interaction Between the Viral RNA Leader Sequence and nsp1 in SARS Coronavirus Luke Cromer, Kaitlin Caughman, Anita Nag
38 [GO] 2023―Apr―13 Abstract 1390: Multiplex measurements of the impacts of ACE2 sequence and cell surface abundance during SARS-like coronavirus entry Nidhi Shukla, Nisha Kamath, Sarah Roelle, Anna Bruchez, Kenneth Matreyek
39 [GO] 2023―Apr―13 Abstract 1624: Global Trends in the Determination of Coronavirus PDB Protein Structures Manfred Philipp, Mary Boldyrev, David Roman, Matthew Mcdevitt, Janet Gonzalez, Cristina Clement
40 [GO] 2023―Apr―13 Abstract 2677: The SARS-CoV-2 Nsp13 Helicase Required for Coronavirus Replication Interacts with Structured Nucleic Acids in a Strand-Specific Manner and Catalyzes a Novel Protein-RNA Remodeling Activity Implicated in the Proofreading Mechanism of the Replication-Transc Adaira Dumm, Joshua Sommers, Lorin Loftus, Martin Jones, Rebecca Lee, Caitlin Haren, Robert Brosh
41 [GO] 2023―Apr―13 Abstract 1382: Visualization and functional annotation of coronavirus spike protein glycoshields Shang-Te Danny Hsu, Tzu-Jing Yang, Pei-Yu Yu, Yu-Xi Tsai, Ning-En Chang, Kay-Hooi Khoo, et al. (+2)
42 [GO] 2023―Apr―13 Abstract 1238: The Role of SARS-CoV Non-structural protein 1 in Regulating RNA stability Kevin Xiong, Kaitlin Bridges, Anita Nag
43 [GO] 2023―Apr―13 Abstract 2075: Thermodynamic Analysis of 1 × 2 Internal Loop Regions of SL1 of SARS-CoV-2 and SL of U6 snRNA Quinn Eaheart, Neena Grover
44 [GO] 2023―Apr―13 Abstract 153: Examination of the affinity of anti-SARS-CoV-2 IgA, which is mucosal immunity, for SARS-CoV-2 BA.4 variant and BA.5 variant Takuma Hayashi, Takuma Hayashi, Nobuo Yaegashi, Ikuo Konishi
45 [GO] 2023―Apr―13 Abstract 1647: Quantification of functional antibody titers in a mouse model of SARS-CoV-2 infection Dulce Hernandez, Rakhi Harne, Brittany Williams, Susan Baldwin, Rhea Coler
46 [GO] 2023―Apr―13 Abstract 1985: SARS-CoV-2 infection alters the breast milk glycomic profile F. Ifthiha Mohideen, Parisa Raeisimakiani, Lara Mahal, Rebecca Powell
47 [GO] 2023―Apr―13 Abstract 2610: Modifications in SARS-CoV-2 N Linker Region Regulate RNA Interactions and Phase Separation Sahana Shah, Hannah Stuwe, Kaitlyn Hughes, Patrick Reardon, Zhen Yu, Elisar Barbar
48 [GO] 2023―Apr―13 Abstract 2676: SARS-CoV-2 Nsp13 Catalytic Efficiency is Regulated by ATP: Mg2+ Stoichiometry and Functional Cooperativity Among Nsp13 Molecules Caitlin Haren, Joshua Sommers, Lorin Loftus, Martin Jones, Rebecca Lee, Adaira Dumm, Robert Brosh
49 [GO] 2023―Apr―13 Abstract 1510: Synthesis and Analysis of the SARS-CoV-2 ORF7a Accessory Protein Transmembrane Domain and Determination of the Oligomerization State Tyler Hobart, Timothy Reichart
50 [GO] 2023―Apr―13 Abstract 2702: Highly synergistic combinations of nanobodies that target SARS-CoV-2 reduce viral load in hACE2 transgenic mice Paul Olivier, Fred Mast, Peter Fridy, Natalia Ketaren, Leslie Miller, Tanmoy Sanyal, et al. (+3)
51 [GO] 2023―Apr―13 Abstract 1997: Assembling a structural model of the SARS-CoV-2 replication and transcription complex from 60+ subunits Jason Perry
52 [GO] 2023―Apr―13 Abstract 2521: AI-enabled multiscale modeling of SARS-CoV-2 replication transcription complex Ramanathan Arvind, Anda Trifan, Defne Ozgulbas, Alexander Brace, Kyle Hippe, Anima Anandkumar, et al. (+3)
53 [GO] 2023―Apr―13 Abstract 2080: Modeling DNA Oligonucleotide Binding to DNA-mimetic Stem-Loop 1 of the SARS-CoV-2 RNA Sophie Gaspel, Neena Grover
54 [GO] 2023―Apr―13 Abstract 2189: The Impact of N-butyldeoxynojirimycin and 1-deoxymannojirimycin on SARS-CoV-2 S1 Subunit and Angiotensin-Converting Enzyme 2 Interaction in Intestinal Epithelial Cells Marianne El Khoury, Dalanda Wanes, Maura Lynch-Miller, Hassan Naim
55 [GO] 2023―Apr―13 SARS-CoV-2 spike ectodomain targets α7 nicotinic acetylcholine receptors Brittany C.V. O’Brien, Lahra Weber, Karsten Hr, Maegan M. Weltzin
56 [GO] 2023―Apr―13 Abstract 1936: Increases in expression of carbohydrate sulfotransferases CHST11 and CHST15 and decline in N-acetylgalactosamine-4-sulfatase (Arylsulfatase B; ARSB) require phospho-p38-MAPK following exposure to SARS-CoV-2 spike protein receptor binding domain in human a Joanne Tobacman, Sumit Bhattacharyya
57 [GO] 2023―Apr―13 Abstract 1569: Assessing the Cholinergic Anti-Inflammatory Response in Human Macrophages Exposed to the Spike Protein of the SARS-CoV-2 Strain from Wuhan, China Randy Irizarry-Alvarez, Manuel Delgado-Vélez, Negin Martin, Jerrel Yakel, José Lasalde-Dominicci
58 [GO] 2023―Apr―13 Abstract 2193: Synthesis of the Transmembrane Domain of the Spike Protein from SARS-CoV-2 Using Solid Phase Peptide Synthesis and Determination of Its Oligomerization State Loyal Grimes, Timothy Reichart
59 [GO] 2023―Apr―13 Abstract 1509: Targeting Spike Glycans to Inhibit SARS-CoV-2 Viral Entry Alex Guseman, Linda Rennick, Sham Nambulli, Fatema Bhinderwhala, David Martinez, Ralph Baric, et al. (+2)
60 [GO] 2023―Apr―13 Abstract 1505: From Pandemic to Providence: The Success of the S-STEM Mentored Pathways Program Post-Pandemic Alexandra Hofler, Mourad Mjahed, Joachim Latzer, Mikael Bergdahl, Byron Purse, Ashley Alchehayed, et al. (+3)
61 [GO] 2023―Apr―13 Abstract 1627: ASBMB at KU: Establishing our student chapter and enriching our community in a post pandemic world Christopher Kywe, Albert Park, Alexandra Coveney, Kai Smith
62 [GO] 2023―Apr―10 SARS-CoV-2 polyprotein substrate regulates the stepwise Mpro cleavage reaction Manju Narwal, Jean-Paul Armache, Thomas J. Edwards, Katsuhiko S. Murakami
63 [GO] 2023―Apr―01 Heat shock protein 90 facilitates SARS-CoV-2 structural protein-mediated virion assembly and promotes virus-induced pyroptosis Zhuangzhuang Zhao, Ling-Dong Xu, Fei Zhang, Qi-Zhang Liang, Yajuan Jiao, Fang-Shu Shi, et al. (+3)
64 [GO] 2023―Feb―17 Structural insights into protection against a SARS-CoV-2 spike variant by T cell receptor (TCR) diversity Daichao Wu, Grigory A. Efimov, Apollinariya V. Bogolyubova, Brian G. Pierce, Roy A. Mariuzza
65 [GO] 2023―Feb―10 Structural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 Main Protease Gabriela Dias Noske, Ellen de Souza Silva, Mariana Ortiz de Godoy, Isabela Dolci, Rafaela Sachetto Fernandes, Rafael Victório Carvalho Guido, et al. (+3)
66 [GO] 2023―Feb―08 The main protease of SARS-CoV-2 cleaves histone deacetylases and DCP1A, attenuating the immune defense of the interferon-stimulated genes Liu Song, Dianbing Wang, Ghulam Abbas, Min Li, Mengmeng Cui, Jufang Wang, et al. (+2)
67 [GO] 2023―Feb―04 Biochemical Analysis of SARS-CoV-2 Nsp13 Helicase Implicated in COVID-19 and Factors that Regulate its Catalytic Functions Joshua A. Sommers, Lorin N. Loftus, Martin P. Jones, Rebecca A. Lee, Caitlin E. Haren, Adaira J. Dumm, Robert M. Brosh
68 [GO] 2023―Jan―28 Expanding and Improving Nanobody Repertoires Using a Yeast Display Method: Targeting SARS-CoV-2 F.R. Cross, P. Fridy, N. Ketaren, F. Mast, S. Li, P. Olivier, et al. (+4)
69 [GO] 2023―Jan―20 SARS-CoV-2-encoded ORF8 protein possesses complement inhibitory properties Jitendra Kumar, Saurabh Dhyani, Prateek Kumar, Nishi Raj Sharma, Surajit Ganguly
70 [GO] 2023―Jan―18 Receptor-binding domain of SARS-CoV-2 is a functional αv-integrin agonist Emma G. Norris, Xuan Sabrina Pan, Denise C. Hocking
71 [GO] 2022―Dec―09 pH profiles of 3-chymotrypsin-like protease (3CLpro) from SARS-CoV-2 elucidate its catalytic mechanism and a histidine residue critical for activity Kenana Al Adem, Juliana C. Ferreira, Samar Fadl, Wael M. Rabeh
72 [GO] 2022―Nov―22 Nanobody derived using a peptide epitope from the Spike protein receptor-binding motif inhibits entry of SARS-CoV-2 variants Nivya Mendon, Rayees Ganie, Shubham Kesarwani, Drisya Dileep, Sarika Sasi, Prakash Lama, et al. (+2)
73 [GO] 2022―Oct―26 Transmembrane serine protease TMPRSS2 implicated in SARS-CoV-2 infection is autoactivated intracellularly and requires N-glycosylation for regulation Yikai Zhang, Shijin Sun, Chunyu Du, Kaixuan Hu, Ce Zhang, Meng Liu, et al. (+2)
74 [GO] 2022―Oct―04 Reconstitution of the SARS-CoV-2 ribonucleosome provides insights into genomic RNA packaging and regulation by phosphorylation Christopher R. Carlson, Armin N. Adly, Maxine Bi, Conor J. Howard, Adam Frost, Yifan Cheng, David O. Morgan
75 [GO] 2022―Sep―22 Host cell membrane proteins located near SARS-CoV-2 spike protein attachment sites are identified using proximity labeling and proteomic analysis Norihiro Kotani, Takanari Nakano, Ryusuke Kuwahara
76 [GO] 2022―Sep―19 SARS-CoV-2 hijacks macropinocytosis to facilitate its entry and promote viral spike-mediated cell-to-cell fusion Yu-Yuan Zhang, Ronghui Liang, Shu-Jie Wang, Zi-Wei Ye, Tong-Yun Wang, Meng Chen, et al. (+8)
77 [GO] 2022―Jun―28 Correction: Exostosin glycosyltransferase 1 reduces porcine reproductive and respiratory syndrome virus infection through proteasomal degradation of nsp3 and nsp5 Xiaoxiao Zhang, Wenjuan Dong, Xun Wang, Zhenbang Zhu, Sheng He, Hui Zhang, et al. (+3)
78 [GO] 2022―May―11 Key dimer interface residues impact the catalytic activity of 3CLpro, the main protease of SARS-CoV-2 Juliana C. Ferreira, Samar Fadl, Wael M. Rabeh
79 [GO] 2022―Apr―22 Structural basis for the in vitro efficacy of nirmatrelvir against SARS-CoV-2 variants Samantha E. Greasley, Stephen Noell, Olga Plotnikova, RoseAnn Ferre, Wei Liu, Ben Bolanos, et al. (+6)
80 [GO] 2022―Apr―10 Replication of the coronavirus genome: a paradox among positive-strand RNA viruses Emeline Grellet, India L’Hôte, Adeline Goulet, Isabelle Imbert
81 [GO] 2022―Mar―10 Prefusion Spike Protein Conformational Changes Are Slower in SARS-CoV-2 than in SARS-CoV-1 Vivek Govind Kumar, Dylan S. Ogden, Ugochi H. Isu, Adithya Polasa, James Losey, Mahmoud Moradi
82 [GO] 2022―Feb―17 Improved SARS-CoV-2 main protease high throughput screening assay using a 5-carboxyfluorescein substrate Scott Legare, Fabian Heide, Ben A. Bailey-Elkin, Jörg Stetefeld
83 [GO] 2022―Feb―11 SARS-CoV-2 accessory protein ORF8 is secreted extracellularly as a glycoprotein homodimer Kazuhiro Matsuoka, Nobuhiko Imahashi, Miki Ohno, Hirotaka Ode, Yoshihiro Nakata, Mai Kubota, et al. (+4)
84 [GO] 2022―Feb―10 Integrin mediates cell entry of the SARS-CoV-2 virus independent of cellular receptor ACE2 Jiamnin Liu, Fan Lu, Yinghua Chen, Edward Plow, Jun Qin
85 [GO] 2022―Feb―07 The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin α5β1 and NF-κB signaling Juan Pablo Robles, Magdalena Zamora, Elva Adan-Castro, Lourdes Siqueiros-Marquez, Gonzalo Martinez de la Escalera, Carmen Clapp
86 [GO] 2022―Feb―04 Phase Separation by the SARS-CoV-2 Nucleocapsid Protein: Consensus and Open Questions Sean M. Cascarina, Eric D. Ross
87 [GO] 2022―Jan―30 Tafenoquine and its derivatives as inhibitors for the Severe Acute Respiratory Syndrome Coronavirus 2 Yeh Chen, Wen-Hao Yang, Hsiao-Fan Chen, Li-Min Huang, Jing-Yan Gao, Cheng-Wen Lin, et al. (+21)
88 [GO] 2022―Jan―25 Elimination of Aicardi Goutières Syndrome Protein SAMHD1 Activates Cellular Innate Immunity and Suppresses SARS-CoV-2 Replication Adrian Oo, Keivan Zandi, Caitlin Shepard, Leda C. Bassit, Katie Musall, Shu Ling Goh, et al. (+4)
89 [GO] 2022―Jan―13 Host E3 ligase HUWE1 attenuates the pro-apoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation Yuzheng Zhou, Rong Zheng, Sixu Liu, Cyrollah Disoma, Ashuai Du, Shiqin Li, et al. (+17)
90 [GO] 2021―Dec―28 Exostosin glycosyltransferase 1 reduces porcine reproductive and respiratory syndrome virus infection through proteasomal degradation of nsp3 and nsp5 Xiaoxiao Zhang, Wenjuan Dong, Xun Wang, Zhenbang Zhu, Sheng He, Hui Zhang, et al. (+3)
91 [GO] 2021―Dec―20 Activation of the SARS-CoV-2 NSP14 3'-5' exoribonuclease by NSP10 and response to antiviral inhibitors Amanda A. Riccio, Eric D. Sullivan, William C. Copeland
92 [GO] 2021―Dec―18 The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms Giulia Paiardi, Stefan Richter, Pasqua Oreste, Chiara Urbinati, Marco Rusnati, Rebecca C. Wade
93 [GO] 2021―Nov―11 Proximity-dependent biotinylation detects associations between SARS coronavirus nonstructural protein 1 and stress granule-associated proteins Yevgeniy A. Gerassimovich, Samantha J. Miladinovski-Bangall, Kaitlin M. Bridges, Linkel Boateng, Lauren E. Ball, Homayoun Valafar, Anita Nag
94 [GO] 2021―Oct―29 A natural product compound inhibits coronaviral replication in vitro by binding to the conserved Nsp9 SARS-CoV-2 protein Dene R. Littler, Miaomiao Liu, Julie L. McAuley, Shea A. Lowery, Patricia T. Illing, Benjamin S. Gully, et al. (+6)
95 [GO] 2021―Oct―29 Reply to Lassaunière: On the functional characterization of the Y453F RBD variant found in cluster 5 SARS-CoV-2 Rafael Bayarri-Olmos, Laust Bruun Johnsen, Anne Rosbjerg, Charlotte Helgstrand, Theresa Bak-Thomsen, Peter Garred, Mikkel-Ole Skjoedt
96 [GO] 2021―Oct―29 SARS-CoV-2 Beta Variant Substitutions Alter Spike Glycoprotein Receptor Binding Domain Structure and Stability Daniel L. Moss, Jay Rappaport
97 [GO] 2021―Oct―25 SARS-CoV-2 Y453F is not the “cluster 5” variant Ria Lassaunière
98 [GO] 2021―Oct―22 Allotypic variation in antigen processing controls antigenic peptide generation from SARS-CoV-2 S1 Spike Glycoprotein George Stamatakis, Martina Samiotaki, Ioannis Temponeras, George Panayotou, Efstratios Stratikos
99 [GO] 2021―Oct―21 Development of a highly specific and sensitive VHH-based sandwich immunoassay for the detection of the SARS-CoV-2 nucleoprotein Marion Gransagne, Gabriel Aymé, Sébastien Brier, Gaëlle Chauveau-Le Friec, Véronique Meriaux, Mireille Nowakowski, et al. (+16)
100 [GO] 2021―Oct―01 Exosome-mediated mRNA Delivery in vivo is safe and can be used to induce SARS-CoV-2 immunity Shang Jui Tsai, Nadia A. Atai, Mafalda Cacciottolo, Justin Nice, Arjang Salehi, Chenxu Guo, et al. (+3)
101 [GO] 2021―Sep―24 D614G mutation in the SARS-CoV-2 spike protein enhances viral fitness by desensitizing it to temperature-dependent denaturation Tzu-Jing Yang, Pei-Yu Yu, Yuan-Chih Chang, Shang-Te Danny Hsu
102 [GO] 2021―Sep―23 An atomistic model of the coronavirus replication-transcription complex as a hexamer assembled around nsp15 Jason K. Perry, Todd C. Appleby, John P. Bilello, Joy Y. Feng, Uli Schmitz, Elizabeth A. Campbell
103 [GO] 2021―Sep―17 Structural and kinetic analyses of holothurian sulfated glycans suggest potential treatment for SARS-CoV-2 infection Rohini Dwivedi, Priyanka Samanta, Poonam Sharma, Fuming Zhang, Sushil K. Mishra, Pavel Kucheryavy, et al. (+6)
104 [GO] 2021―Sep―17 Receptor binding, immune escape, and protein stability direct the natural selection of SARS-CoV-2 variants Vaibhav Upadhyay, Alexandra Lucas, Sudipta Panja, Ryuki Miyauchi, Krishna M.G. Mallela
105 [GO] 2021―Sep―07 Deamidation drives molecular aging of the SARS-CoV-2 spike protein receptor-binding motif Ramiro Lorenzo, Lucas A. Defelipe, Lucio Aliperti, Stephan Niebling, Tânia F. Custódio, Christian Löw, et al. (+8)
106 [GO] 2021―Aug―31 Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2 Jérémie Prévost, Jonathan Richard, Romain Gasser, Shilei Ding, Clément Fage, Sai Priya Anand, et al. (+17)
107 [GO] 2021―Aug―27 SARS-CoV-2 S2P spike ages through distinct states with altered immunogenicity Adam S. Olia, Yaroslav Tsybovsky, Steven J. Chen, Cuiping Liu, Alexandra F. Nazzari, Li Ou, et al. (+13)
108 [GO] 2021―Aug―21 S-acylation of SARS-CoV-2 Spike Protein: Mechanistic Dissection, In Vitro Reconstitution and Role in Viral Infectivity Robbins Puthenveetil, Cheng Man Lun, R. Elliot Murphy, Liam B. Healy, Geraldine Vilmen, Eric T. Christenson, et al. (+2)
109 [GO] 2021―Aug―10 Structural basis of biased T cell receptor recognition of an immunodominant HLA-A2 epitope of the SARS-CoV-2 spike protein Priyanka Chaurasia, Thi H.O. Nguyen, Louise C. Rowntree, Jennifer A. Juno, Adam K. Wheatley, Stephen J. Kent, et al. (+3)
110 [GO] 2021―Aug―06 Correction: Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action Egor P. Tchesnokov, Calvin J. Gordon, Emma Woolner, Dana Kocincova, Jason K. Perry, Joy Y. Feng, et al. (+2)
111 [GO] 2021―Aug―04 The SARS-CoV-2 Nsp3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation induced by interferon signalling Lilian Cristina Russo, Rebeka Tomasin, Isaac Araújo Matos, Antonio Carlos Manucci, Sven T. Sowa, Katie Dale, et al. (+6)
112 [GO] 2021―Jul―28 Binding of a pyrimidine RNA base-mimic to SARS-CoV-2 non-structural protein 9 Dene R. Littler, Biswaranjan Mohanty, Shea A. Lowery, Rhys N. Colson, Benjamin S. Gully, Stanley Perlman, et al. (+2)
113 [GO] 2021―Jul―05 Recombinant SARS-CoV-2 envelope protein traffics to the trans-Golgi network following amphipol-mediated delivery into human cells James M. Hutchison, Ricardo Capone, Dustin D. Luu, Karan H. Shah, Arina Hadziselimovic, Wade D. Van Horn, Charles R. Sanders
114 [GO] 2021―Jun―30 Famotidine inhibits Toll-like receptor 3-mediated inflammatory signaling in SARS-CoV2 infection Rukmini Mukherjee, Anshu Bhattacharya, Denisa Bojkova, Ahmad Reza Mehdipour, Donghyuk Shin, Khadija Shahed Khan, et al. (+10)
115 [GO] 2021―Jun―20 Effect of clinical isolate or cleavage site mutations in the SARS-CoV-2 spike protein on protein stability, cleavage, and cell-cell fusion Chelsea T. Barrett, Hadley E. Neal, Kearstin Edmonds, Carole L. Moncman, Rachel Thompson, Jean M. Branttie, et al. (+4)
116 [GO] 2021―Jun―09 Decoding molnupiravir-induced mutagenesis in SARS-CoV-2 Luis Menéndez-Arias
117 [GO] 2021―May―31 Reply to Hayashi and Konishi: Noneffect of SARS-CoV-2 spike glycoprotein Y217N mutation on affinity between virus and ACE2 Yan-Dong Tang
118 [GO] 2021―May―28 Role of host factors in SARS-CoV-2 entry John P. Evans, Shan-Lu Liu
119 [GO] 2021―May―27 Noneffect of SARS-CoV-2 spike glycoprotein Y217N mutation on affinity between the virus and ACE2 Takuma Hayashi, Ikuo Konishi
120 [GO] 2021―May―23 Arginine Methylation of SARS-Cov-2 Nucleocapsid Protein Regulates RNA Binding, its Ability to Suppress Stress Granule Formation and Viral Replication Ting Cai, Zhenbao Yu, Zhen Wang, Chen Liang, Stéphane Richard
121 [GO] 2021―May―11 Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template Calvin J. Gordon, Egor P. Tchesnokov, Raymond F. Schinazi, Matthias Götte
122 [GO] 2021―May―07 The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection Anthony J. Carlos, Dat P. Ha, Da-Wei Yeh, Richard Van Krieken, Chun-Chih Tseng, Pu Zhang, et al. (+3)
123 [GO] 2021―Apr―23 Inhibition of acid sphingomyelinase by ambroxol prevents SARS-CoV-2 entry into epithelial cells Alexander Carpinteiro, Barbara Gripp, Markus Hoffmann, Stefan Pöhlmann, Nicolas Hoertel, Michael J. Edwards, et al. (+4)
124 [GO] 2021―Apr―20 Downregulation of miR-218 by porcine reproductive and respiratory syndrome virus facilitates viral replication via inhibition of type I interferon responses Lin Zhang, Lu Zhang, Yu Pan, Junxin Gao, Yunfei Xu, Xi Li, et al. (+3)
125 [GO] 2021―Mar―12 The SARS-CoV-2 Y453F mink variant displays a pronounced increase in ACE-2 affinity but does not challenge antibody neutralization Rafael Bayarri-Olmos, Anne Rosbjerg, Laust Bruun Johnsen, Charlotte Helgstrand, Theresa Bak-Thomsen, Peter Garred, Mikkel-Ole Skjoedt
126 [GO] 2021―Feb―25 Glucosylceramide synthase inhibitors prevent replication of SARS-CoV-2 and Influenza virus Einat.B. Vitner, Hagit Achdout, Roy Avraham, Boaz Politi, Lilach Cherry, Hadas Tamir, et al. (+5)
127 [GO] 2021―Feb―24 Evaluating angiotensin-converting enzyme 2-mediated SARS-CoV-2 entry across species Hong-Liang Zhang, Yu-Ming Li, Jing Sun, Yu-Yuan Zhang, Tong-Yun Wang, Ming-Xia Sun, et al. (+6)
128 [GO] 2021―Feb―04 How glycobiology can help us treat and beat the COVID-19 pandemic Ricardo D. Lardone, Yohana C. Garay, Pedro Parodi, Sofia de la Fuente, Genaro Angeloni, Eduardo O. Bravo, et al. (+2)
129 [GO] 2021―Jan―30 Potent mouse monoclonal antibodies that block SARS-CoV-2 infection Youjia Guo, Atsushi Kawaguchi, Masaru Takeshita, Takeshi Sekiya, Mikako Hirohama, Akio Yamashita, et al. (+2)
130 [GO] 2021―Jan―19 SARS-CoV-2 infects cells following viral entry via clathrin-mediated endocytosis Armin Bayati, Rahul Kumar, Vincent Francis, Peter S. McPherson
131 [GO] 2021―Jan―18 The effects of processing inhibitors of N-linked oligosaccharides on the intracellular migration of glycoprotein E2 of mouse hepatitis virus and the maturation of coronavirus particles. R Repp, T Tamura, C B Boschek, H Wege, R T Schwarz, H Niemann
132 [GO] 2021―Jan―06 Signal recognition particle-dependent insertion of coronavirus E1, an intracellular membrane glycoprotein. P Rottier, J Armstrong, D I Meyer
133 [GO] 2021―Jan―06 O-glycosylation of the coronavirus M protein. Differential localization of sialyltransferases in N- and O-linked glycosylation. J.K. Locker, G Griffiths, M.C. Horzinek, P.J. Rottier
134 [GO] 2021―Jan―06 Membrane assembly of the triple-spanning coronavirus M protein. Individual transmembrane domains show preferred orientation. J.K. Locker, J.K. Rose, M.C. Horzinek, P.J. Rottier
135 [GO] 2021―Jan―05 Membrane integration and intracellular transport of the coronavirus glycoprotein E1, a class III membrane glycoprotein. T Mayer, T Tamura, M Falk, H Niemann
136 [GO] 2020―Dec―02 Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection Pablo Fuentes-Prior
137 [GO] 2020―Nov―24 The SARS-CoV-2 Envelope and Membrane proteins modulate maturation and retention of the Spike protein, allowing assembly of virus-like particles Bertrand Boson, Vincent Legros, Bingjie Zhou, Eglantine Siret, Cyrille Mathieu, François-Loïc Cosset, et al. (+2)
138 [GO] 2020―Nov―20 SARS-CoV-2 viral budding and entry can be modeled using BSL-2 level virus-like particles Caroline B. Plescia, Emily A. David, Dhabaleswar Patra, Ranjan Sengupta, Souad Amiar, Yuan Su, Robert V. Stahelin
139 [GO] 2020―Oct―29 High affinity binding of SARS-CoV-2 spike protein enhances ACE2 carboxypeptidase activity Jinghua Lu, Peter D. Sun
140 [GO] 2020―Oct―19 Mouse Ifit1b is a cap1-RNA binding protein which inhibits mouse coronavirus translation and is regulated by complexing with Ifit1c Harriet V Mears, Trevor R Sweeney
141 [GO] 2020―Oct―15 Unusual zwitterionic catalytic site of SARS-CoV-2 main protease revealed by neutron crystallography Daniel W. Kneller, Gwyndalyn Phillips, Kevin L Weiss, Swati Pant, Qiu Zhang, Hugh M O'Neill, et al. (+2)
142 [GO] 2020―Oct―14 Coronavirus infection and PARP expression dysregulate the NAD Metabolome: an actionable component of innate immunity Collin D Heer, Daniel J Sanderson, Lynden S Voth, Yousef M.O. Alhammad, Mark S Schmidt, Samuel A.J. Trammell, et al. (+4)
143 [GO] 2020―Sep―25 Presence of hyaluronan in lung alveoli in severe Covid-19 - an opening for new treatment options? Urban Hellman, Mats G Karlsson, Anna Engström-Laurent, Sara Cajander, Luiza Dorofte, Clas Ahlm, et al. (+2)
144 [GO] 2020―Sep―24 Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action Egor P Tchesnokov, Calvin J Gordon, Emma Woolner, Dana Kocincova, Jason K Perry, Joy Y. Feng, et al. (+2)
145 [GO] 2020―Sep―11 Sphingosine prevents binding of SARS-CoV-2 spike to its cellular receptor ACE2 Michael J. Edwards, Katrin Anne Becker, Barbara Gripp, Markus Hoffmann, Simone Keitsch, Barbara Wilker, et al. (+11)
146 [GO] 2020―Sep―04 A blueprint for academic labs to produce SARS-CoV-2 RT-qPCR test kits Samantha J. Mascuch, Sara Fakhretaha-Aval, Jessica C. Bowman, Minh Thu H. Ma, Gwendell Thomas, Bettina Bommarius, et al. (+29)
147 [GO] 2020―Aug―06 Impaired NLRP3 inflammasome activation/pyroptosis leads to robust inflammatory cell death via caspase-8/RIPK3 during coronavirus infection Min Zheng, Evan Peter Williams, R. K. Subbarao Malireddi, Rajendra Karki, Balaji Banoth, Amanda Burton, et al. (+4)
148 [GO] 2020―Jun―25 SARS-CoV-2 (COVID-19) structural and evolutionary dynamicome: Insights into functional evolution and human genomics Ruchir Gupta, Jacob Charron, Cynthia L Stenger, Jared Painter, Hunter Steward, Taylor W Cook, et al. (+16)
149 [GO] 2020―Jun―25 Inhibition of SARS-CoV-2 by type I and type III interferons Ulrike Felgenhauer, Andreas Schoen, Hans Henrik Gad, Rune Hartmann, Andreas R Schaubmar, Klaus Failing, et al. (+2)
150 [GO] 2020―Jun―23 Structural and functional conservation of the programmed -1 ribosomal frameshift signal of SARS coronavirus 2 (SARS-CoV-2) Jamie A. Kelly, Alexandra N. Olson, Krishna Neupane, Sneha Munshi, Josue San Emeterio, Lois Pollack, et al. (+2)
151 [GO] 2020―Apr―13 Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency Calvin J Gordon, Egor P Tchesnokov, Emma Woolner, Jason K Perry, Joy Y. Feng, Danielle P Porter, Matthias Gotte
152 [GO] 2020―Apr―10 Halting coronavirus polymerase Robert N. Kirchdoerfer
153 [GO] 2020―Feb―25 The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus Calvin J Gordon, Egor P Tchesnokov, Joy Y. Feng, Danielle P Porter, Matthias Gotte
154 [GO] 2019―Dec―28 Pulmonary Surfactant Lipids Inhibit Infections with the Pandemic H1N1 Influenza Virus in Several Animal Models Mari Numata, James R Mitchell, Jennifer L Tipper, Jeffery D Brand, John E Trombley, Yoji Nagashima, et al. (+4)

154 Results       Page 1


Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.008 sec